Feb 22 (Reuters) - CogState Ltd (CGS) :
- REMAINS CONFIDENT COGSTATE IS WELL POSITIONED FOR GROWTH AND WILL RECOMMENCE SHARE BUYBACK
- RESOLVED TO COMMENCE A FURTHER ON-MARKET SHARE BUY-BACK OF UP TO 5 MILLION OF ISSUED ORDINARY SHARES OVER NEXT 12 MONTHS
- EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24 COMPARED WITH 1H24
- CUSTOMER ENGAGEMENT ON NEW CLINICAL TRIALS EXPECTED TO REMAIN STRONG IN FY24
- EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24 COMPARED WITH 1H24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.020(1.00%) |
Mkt cap ! $345.8M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.07 | $1.98 | $509.1K | 251.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 22222 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| CGS (ASX) Chart |